John Lunger - Mar 3, 2022 Form 4 Insider Report for GENOCEA BIOSCIENCES, INC. (GNCA)

Role
Director
Signature
/s/ Diantha Duvall, Attorney-in-Fact for John Lunger
Stock symbol
GNCA
Transactions as of
Mar 3, 2022
Transactions value $
$0
Form type
4
Date filed
3/7/2022, 05:14 PM
Previous filing
Jan 18, 2022
Next filing
Jul 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GNCA Stock Option (Right to Buy) Award $0 +30K $0.00 30K Mar 3, 2022 Common Stock 30K $1.06 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are scheduled to vest in 36 equal monthly installments beginning on the first monthly anniversary of the grant date.